Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Dolichol-20)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST000004 AN000008 Lipidomics studies on NIDDK / NIST human plasma samples Blood Human LIPID MAPS nM
ST000916 AN001493 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma Blood Human Fatty liver disease LIPID MAPS nM
ST000917 AN001499 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 3:Urine Urine Human Fatty liver disease LIPID MAPS nM
ST001065 AN001742 Lipidomics analysis for aged mice brain cortex (part-II) Adipose tissue Mouse Takeda Pharmaceutical Company Limited Peak area
ST001065 AN001742 Lipidomics analysis for aged mice brain cortex (part-II) Brain Mouse Takeda Pharmaceutical Company Limited Peak area
ST001065 AN001742 Lipidomics analysis for aged mice brain cortex (part-II) Liver Mouse Takeda Pharmaceutical Company Limited Peak area
ST001065 AN001742 Lipidomics analysis for aged mice brain cortex (part-II) Muscle Mouse Takeda Pharmaceutical Company Limited Peak area
ST001289 AN002142 Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses Macrophages Mouse LIPID MAPS pmol/1E6 cells
ST000915 AN001487 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver Liver Human Fatty liver disease LIPID MAPS pmol/mg
ST001288 AN002141 Subcellular organelle lipidomics in TLR-4-activated macrophages Macrophages Mouse LIPID MAPS pmol/mg protein
ST000005 AN000012 Timecourse on RAW 264.7 cells treated with Kdo2-Lipid A and compactin Macrophages Mouse LIPID MAPS pmol/ug DNA
ST002094 AN003422 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic raw intensity
  logo